These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9316776)

  • 1. Autoantibodies against oxidized LDL. A potential marker for atherosclerosis.
    Wu JT; Wu LL
    Clin Lab Med; 1997 Sep; 17(3):595-604. PubMed ID: 9316776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions.
    Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
    Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against oxidized LDL for non-invasive diagnosis of atherosclerotic vascular disease.
    de Geest B; Collen D
    Eur Heart J; 2001 Sep; 22(17):1517-8. PubMed ID: 11492979
    [No Abstract]   [Full Text] [Related]  

  • 7. Significantly higher levels of oxidized LDL autoantibody in coronary artery disease patients.
    Liang KW; Huang JL; Kao CH; Hsueh CW; Ho HY; Lee WL; Wang KY; Huang DS; Chen YT; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):101-6. PubMed ID: 10677919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A vaccine for protection against atherosclerosis. Oxidized LDL plays a major role in the immunologic defence].
    Nilsson J; Fredrikson GN
    Lakartidningen; 2004 May; 101(19):1700-1, 1704-5. PubMed ID: 15188583
    [No Abstract]   [Full Text] [Related]  

  • 9. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.
    Nakajima K; Nakano T; Tanaka A
    Clin Chim Acta; 2006 May; 367(1-2):36-47. PubMed ID: 16448638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody.
    Wang J; Zhang C; Gong J; Zhu Y; Fu L; Wang X; Li K
    Clin Chim Acta; 2007 Oct; 385(1-2):73-8. PubMed ID: 17719023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of oxidation of lipoproteins in the pathogenesis of atherosclerosis].
    Picard S
    Pathol Biol (Paris); 1996 Jan; 44(1):46-50. PubMed ID: 8734300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against ox-LDL serum levels in patients with hepatocellular carcinoma.
    Motta M; Pistone G; Franzone AM; Romeo MA; Di Mauro S; Giugno I; Ruello P; Malaguarnera M
    Panminerva Med; 2003 Mar; 45(1):69-73. PubMed ID: 12682623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
    Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
    Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance].
    Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is there a relation between serum ferritin levels, oxidized LDL antibodies and vitamins and risk for coronary atherosclerosis].
    Soska V
    Vnitr Lek; 2004 Mar; 50(3):183-5. PubMed ID: 15125366
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
    J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
    Hulthe J
    Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
    Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
    Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
    Zhou X; Paulsson G; Stemme S; Hansson GK
    J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.